Promoter methylation precedes chromosomal alterations in colorectal cancer development

Cellular Oncology

Volumn 28, Issue 5-6, 2006, Pages 247-257

  Derks, Sarah ^a   Postma, Cindy ^b   Moerkerk, Peter T M ^a   Van Den Bosch, Sandra M ^a   Carvalho, Beatriz ^b   Hermsen, Mario A J A ^c   Giaretti, Walter ^d   Herman, James G ^e   Weijenberg, Matty P ^a   Bruïne, Adriaan P De ^a   Meijer, Gerrit A ^b   Van Engeland, Manon ^a,f  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^d UNIVERSITY OF GENOA   (Italy)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chromosomal instability; Colorectal cancer; Genetic alterations; Promoter methylation

Indexed keywords

APC PROTEIN; K RAS PROTEIN; PROTEIN P14; PROTEIN P16; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 5;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME ABERRATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); TIME FACTORS;

EID: 33845607724     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Y. Akiyama, N. Watkins, H. Suzuki, K.W. Jair, M. van Engeland, M. Esteller, H. Sakai, C.Y. Ren, Y. Yuasa, J.G. Herman and S.B. Baylin, GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer, Mol. Cell. Biol. 23 (2003), 8429-8439.
2. J.W. Arends, Molecular interactions in the Vogelstein model of colorectal carcinoma, J. Pathol. 190 (2000), 412-416.
3. S.B. Baylin and J.E. Ohm, Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6 (2006), 107-116.
4. J. Bertholon, Q. Wang, N. Falette, C. Verny, J. Auclair, C. Chassot, C. Navarro, J.C. Saurin and A. Puisieux, Chfr inactivation is not associated to chromosomal instability in colon cancers, Oncogene 22 (2003), 8956-8960.
5. J.C. Brandes, M. van Engeland, K.A. Wouters, M.P. Weijenberg and J.G. Herman, CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype, Carcinogenesis 26 (2005), 1152-1156.
6. B. Carvalho, E. Ouwerkerk, G.A. Meijer and B. Ylstra, High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides, J. Clin. Pathol. 57 (2004), 644-646.
7. W. Chen, T.K. Cooper, C.A. Zahnow, M. Overholtzer, Z. Zhao, M. Ladanyi, J.E. Karp, N. Gokgoz, J.S. Wunder, I.L. Andrulis, A.J. Levine, J.L. Mankowski and S.B. Baylin, Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis, Cancer Cell 6 (2004), 387-398.
8. P.G. Corn, M.K. Summers, F. Fogt, A.K. Virmani, A.F. Gazdar, T.D. Halazonetis and W.S. El-Deiry, Frequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer, Carcinogenesis 24 (2003), 47-51.
9. J.F. Costello, B.W. Futscher, K. Tano, D.M. Graunke and R.O. Pieper, Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells, J. Biol. Chem. 269 (1994), 17228-17237.
10. J.M. Cunningham, E.R. Christensen, D.J. Tester, C.Y. Kim, P.C. Roche, L.J. Burgart and S.N. Thibodeau, Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability, Cancer Res. 58 (1998), 3455-3460.
11. S. Derks, M.H. Lentjes, D.M. Hellebrekers, A.P. de Bruine, J.G. Herman and M. van Engeland, Methylation-specific PCR unraveled, Cell Oncol. 26 (2004), 291-299.
12. M. Esteller, P.G. Corn, S.B. Baylin and J.G. Herman, A gene hypermethylation profile of human cancer, Cancer Res. 61 (2001) 3225-3229.
13. M. Esteller, A. Sparks, M. Toyota, M. Sanchez-Cespedes, G. Capella, M.A. Peinado, S. Gonzalez, G. Tarafa, D. Sidransky, S.J. Meltzer, S.B. Baylin and J.G. Herman, Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer, Cancer Res. 60 (2000), 4366-4371.
14. M. Esteller, S. Tortola, M. Toyota, G. Capella, M.A. Peinado, S.B. Baylin and J.G. Herman, Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status, Cancer Res. 60 (2000), 129-133.
15. R. Etzioni, N. Urban, S. Ramsey, M. McIntosh, S. Schwartz, B. Reid, J. Radich, G. Anderson and L. Hartwell, The case for early detection, Nat. Rev. Cancer 3 (2003), 243-252.
16. E.R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell 61 (1990), 759-767.
17. R.A. Gatenby and T.L. Vincent, An evolutionary model of carcinogenesis, Cancer Res. 63 (2003), 6212-6220.
18. W. Giaretti, A. Rapallo, A. Sciutto, B. Macciocu, E. Geido, M.A. Hermsen, C. Postma, J.P. Baak, R.A. Williams and G.A. Meijer, Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer, Anal. Cell Pathol. 21 (2000), 49-57.
19. A. Goel, C.N. Arnold, D. Niedzwiecki, D.K. Chang, L. Ricciardiello, J.M. Carethers, J.M. Dowell, L. Wasserman, C. Compton, R.J. Mayer, M.M. Bertagnolli and C.R. Boland, Characterization of sporadic colon cancer by patterns of genomic instability, Cancer Res. 63 (2003), 1608-1614.
20. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin and S.B. Baylin, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 9821-9826.
21. J.G. Herman, A. Merlo, L. Mao, R.G. Lapidus, J.P. Issa, N.E. Davidson, D. Sidransky and S.B. Baylin, Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res. 55 (1995), 4525-4530.
22. M. Hermsen, C. Postma, J. Baak, M. Weiss, A. Rapallo, A. Sciutto, G. Roemen, J.W. Arends, R. Williams, W. Giaretti, A. De Goeij and G. Meijer, Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability, Gastroenterology 123 (2002), 1109-1119.
23. H.S. Hsu, Y.C. Wang, R.C. Tseng, J.W. Chang, J.T. Chen, C.M. Shih and C.Y. Chen, 5′ cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer, Clin. Cancer Res. 10 (2004), 4734-4741.
24. M. Ilyas and I.P. Tomlinson, Genetic pathways in colorectal cancer, Histopathology 28 (1996), 389-399.
25. K. Jong, E. Marchiori, G. Meijer, A.V. Vaart and B. Ylstra, Breakpoint identification and smoothing of array comparative genomic hybridization data, Bioinformatics 20 (2004), 3636-3637.
26. H. Katoh, T. Shibata, A. Kokubu, H. Ojima, M. Fukayama, Y. Kanai and S. Hirohashi, Epigenetic instability and chromosomal instability in hepatocellular carcinoma, Am. J. Pathol. 168 (2006), 1375-1384.
27. K. Kawakami, A. Ruszkiewicz, G. Bennett, J. Moore, F. Grieu, G. Watanabe and B. Iacopetta, DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer, Br. J. Cancer 94 (2006), 593-598.
28. C. Lengauer, K.W. Kinzler and B. Vogelstein, Genetic instabilities in human cancers, Nature 396 (1998), 643-649.
29. K. Lenhard, G.T. Bommer, S. Asutay, R. Schauer, T. Brabletz, B. Goke, R. Lamerz and F.T. Kolligs, Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer, Clin. Gastroenterol. Hepatol. 3 (2005), 142-149.
30. I.D. Markl and P.A. Jones, Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer, Cancer Res. 58 (1998), 5348-5353.
31. W. Polkowski, J.P. Baak, J.J. van Lanschot, G.A. Meijer, L.T. Schuurmans, F.J. Ten Kate, H. Obertop and G.J. Offerhaus, Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation, J. Pathol. 184 (1998), 161-168.
32. C. Postma, M.A. Hermsen, J. Coffa, J.P. Baak, J.D. Mueller, E. Mueller, B. Bethke, J.P. Schouten, M. Stolte and G.A. Meijer, Chromosomal instability in flat adenomas and carcinomas of the colon, J. Pathol. 205 (2005), 514-521.
33. K.D. Robertson and P.A. Jones, The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53, Mol. Cell Biol. 18 (1998), 6457-6473.
34. L. Shen, Y. Kondo, S.R. Hamilton, A. Rashid and J.P. Issa, P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53, Gastroenterology 124 (2003), 626-633.
35. L. Shen, Y. Kondo, G.L. Rosner, L. Xiao, N.S. Hernandez, J. Vilaythong, P.S. Houlihan, R.S. Krouse, A.R. Prasad, J.G. Einspahr, J. Buckmeier, D.S. Alberts, S.R. Hamilton and J.P. Issa, MGMT promoter methylation and field defect in sporadic colorectal cancer, J. Natl. Cancer Inst. 97 (2005), 1330-1338.
36. A.M. Snijders, N. Nowak, R. Segraves, S. Blackwood, N. Brown, J. Conroy, G. Hamilton, A.K. Hindle, B. Huey, K. Kimura, S. Law, K. Myambo, J. Palmer, B. Ylstra, J.P. Yue, J.W. Gray, A.N. Jain, D. Pinkel and D.G. Albertson, Assembly of microarrays for genome-wide measurement of DNA copy number, Nat. Genet. 29 (2001), 263-264.
37. T.D. Tlsty, Y.G. Crawford, C.R. Holst, C.A. Fordyce, J. Zhang, K. McDermott, K. Kozakiewicz and M.L. Gauthier, Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis, J. Mammary Gland. Biol. Neoplasia 9 (2004), 263-274.
38. T.D. Tlsty, S.R. Romanov, B.K. Kozakiewicz, C.R. Holst, L.M. Haupt and Y.G. Crawford, Loss of chromosomal integrity in human mammary epithelial cells subsequent to escape from senescence, J. Mammary Gland. Biol. Neoplasia 6 (2001), 235-243.
39. Y. Tokumaru, K. Yamashita, M. Osada, S. Nomoto, D.I. Sun, Y. Xiao, M.O. Hoque, W.H. Westra, J.A. Califano and D. Sidransky, Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing, Cancer Res. 64 (2004), 5982-5987.
40. M. Toyota, Y. Sasaki, A. Satoh, K. Ogi, T. Kikuchi, H. Suzuki, H. Mita, N. Tanaka, F. Itoh, J.P. Issa, K.W. Jair, K.E. Schuebel, K. Imai and T. Tokino, Epigenetic inactivation of CHFR in human tumors, Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 7818-7823.
41. M. van Engeland, G.M. Roemen, M. Brink, M.M. Pachen, M.P. Weijenberg, A.P. de Bruine, J.W. Arends, P.A. van den Brandt, A.F. de Goeij and J.G. Herman, K-ras mutations and RASSF1A promoter methylation in colorectal cancer, Oncogene 21 (2002), 3792-3795.
42. M. van Engeland, M.P. Weijenberg, G.M. Roemen, M. Brink, A.P. de Bruine, R.A. Goldbohm, P.A. van den Brandt, S.B. Baylin, A.F. de Goeij and J.G. Herman, Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer, Cancer Res. 63 (2003), 3133-3137.
43. B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, M. Leppert, Y. Nakamura, R. White, A.M. Smits and J.L. Bos, Genetic alterations during colorectal-tumor development, N. Engl. J. Med. 319 (1988), 525-532.
44. M.D. Vos, A. Martinez, C. Elam, A. Dallol, B.J. Taylor, F. Latif and G.J. Clark, A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability, Cancer Res. 64 (2004), 4244-4250.
45. K. Yamashita, T. Dai, Y. Dai, F. Yamamoto and M. Perucho, Genetics supersedes epigenetics in colon cancer phenotype, Cancer Cell 4 (2003), 121-131.
46. Y. Zhang, Y. Xiong and W.G. Yarbrough, ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways, Cell 92 (1998), 725-734.